Category: carcinoid syndrome

Carcinoid Syndrome, Live Online Event, June 2018, Dr. David Metz, Bonnie Bennett

Patient & Caregiver Education on Carcinoid Syndrome: Talking to Your Doctor About Symptoms, Diet, and Treatment

June 5, 2018
A  Free, Live Online Event on Wednesday, June 20, 3:00-4:00 pm EST Click Here to Register

 

Last Spring, we were pleased to create an interactive resource for people living with Carcinoid Syndrome with our partner CancerCoachLive – we’ve teamed…

READ MORE
Michael A. Morse, MD

Carcinoid Syndrome Web Series Continues with Presentation by Michael A. Morse, MD

September 5, 2017

The neuroendocrine tumor (NET) community is invited to attend a live national webcast by Michael A. Morse, MD (pictured below) on “Testing for Neuroendocrine Tumors and Carcinoid Syndrome” on Wednesday, September 13 at 7:00 pm EST, …

READ MORE
Carcinoid Syndrome Web Series 2017_2

New Carcinoid Syndrome Web Series: Education, Testing and Nutrition

July 30, 2017

The neuroendocrine tumor (NET) community is invited to attend a new national webinar series on carcinoid syndrome, beginning on Wednesday, August 23, 2017 with a presentation by Eric H. Liu, MD, neuroendocrine surgeon at the Rocky Mountain Cancer…

READ MORE
Carcinoid Syndrome Live Event, Dr. Edward Wolin banner

Patient Education on Carcinoid Syndrome: From Diagnosis to Treatment

February 17, 2017

A Live Online Event on Wednesday, March 1, 11 am to 12 noon Eastern Standard Time

Ask Your Questions during the Live Program or Submit Them in Advance

Cancer Coach Live, in partnership with the Carcinoid Cancer Foundation, is presenting a special patient…

READ MORE
Sandostatin, Celebrating 25 Years of Commitment

Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program

March 31, 2014

A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.

With the Sandostatin® LAR Depot Co-Pay Assistance Program

READ MORE
Pablo Lapuerta, MD

Lexicon Pharmaceuticals Begins Phase 3 Clinical Trial of Telotristat Etiprate in Patients with Carcinoid Syndrome

December 4, 2012

Patients with metastatic carcinoid syndrome will have the opportunity to participate in a new Phase 3 clinical trial of Lexicon Pharmaceutical’s telotristat etiprate (LX1032), an oral drug candidate designed to treat carcinoid syndrome by reducing…

READ MORE
Lexicon Headquarters

Lexicon Pharmaceuticals Granted Orphan Drug Designation by FDA for Carcinoid Syndrome Treatment

April 2, 2012

Lexicon Pharmaceuticals, Inc. has been granted Orphan Drug Designation for telotristat etiprate (LX1032) by the U.S. Food and Drug Administration (FDA).  LX1032 is used to treat carcinoid syndrome, a chronic condition caused by neuroendocrine …

READ MORE
Zebra

Now Recruiting: Carcinoid Syndrome Patients to Participate in Clinical Trial

June 17, 2011

Ipsen is recruiting patients with a history of carcinoid syndrome to participate in a clinical study to evaluate the effect of Somatuline® Depot (Lanreotide Autogel),  a somatostatin analog (SSTa) similar to octreotide, on the control of symptoms…

READ MORE
Healthy Body, Healthy Mind

Neuroendocrine Tumors Featured on Healthy Body, Healthy Mind Television Series

February 11, 2011

For a comprehensive overview of neuroendocrine tumors, watch this fascinating video on the Healthy Body, Healthy Mind television series. Every episode on the health and wellness TV series focuses on the stories of real people; people who are working…

READ MORE
WebMd logo

WebMD Articles Raise Awareness about Carcinoid Cancer

January 30, 2011

Understanding carcinoid tumors, carcinoid syndrome, and treatments for carcinoid when surgery is not an option are the focus of three feature articles by Ellen Greenlaw on WebMD.com this month.  For these articles, Ms. Greenlaw sought the expertise…

READ MORE